T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development

Canadian Journal of Infectious Diseases

Volumn 9, Issue 2, 1998, Pages 99-109

  Yang, X ^a   Brunham, R C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Cell mediated immunity; Chlamydia trachomatis; Cytokine; Th1 Th2; Vaccine

Indexed keywords

BACTERIAL VACCINE;

CELLULAR IMMUNITY; CHLAMYDIA TRACHOMATIS; HELPER CELL; HOST RESISTANCE; HUMAN; REVIEW; T LYMPHOCYTE;

EID: 0031976523     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/1998/395297     Document Type: Review

References (138)

1. Dawson CR, Jones BR, Tarizzo ML. A guide to trachoma control. In: Programmes for the Prevention of Blindness. Geneva: World Health Organization, 1981.
2. Brunham RC, Peeling RW. Chlamydia trachomatis antigens: Role in immunity and pathogenesis. Infect Agents Dis 1984;3:218-33.
3. Ward ME. The immunobiology and immunopathology of chlamydial infections. APMIS 1995;103:769-96.
4. Peeling RW, Brunham RC. Chlamydiae as pathogens: new species and new issues. Emerg Infect Dis 1996;2:307-19.
5. Brossay L, Villeneuve A, Paradis G, Cote L, Mourad W, Hebert J. Mimicry of a neutralizing epitope of the major outer membrane protein of Chlamydia trachomatis by antiidiotypic antibodies. Infect Immun 1994;62:341-7.
6. Conlan JW, Ferris S, Carke IN, Ward ME. Isolation of recombinant fragments of the major outer-membrane protein of Chlamydia trachomatis: their potential as subunit vaccines. J Gen Microbiol 1990;136:2013-20.
7. Cotter TW, Meng Q, Shen Z-L, Zhang Y-X, Su H, Caldwell HD. Protective efficacy of major outer membrane protein-specific immunoglobulin a (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital infection. Infect Immun 1995;63:4704-14.
8. Grayston JT, Wang S-P. The potential for vaccine against infection of the genital tract with Chlamydia trachomatis. Sex Transm Dis 1978;5:73-7.
9. Murray ES, Charbonnet LT, Macdonald B. Immunity to chlamydial infections of the eye. I. The role of circulatory and secretory antibodies in resistance to reinfection with guinea pig inclusion conjunctivitis. J Immunol 1973;110:1518-25.
10. Rank RG, White HJ, Barron AL. Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect Immun 1979;26:573-9.
11. Su H, Caldwell HD. Immunogenicity of a chimeric peptide corresponding to T helper and B cell epitopes of Chlamydia trachomatis major outer membrane protein. J Exp Med 1992;175:227-35.
12. Toye B, Zhong G, Peeling R, Brunham RC. Immunologic characterization of a cloned fragment containing the species-specific epitope from the major outer membrane protein of Chlamydia trachomatis. Infect Immun 1990;58:3909-13.
13. Zhong G, Berry J, Brunham RC. Antibody recognition of a neutralization epitope on the major outer membrane protein of Chlamydia trachomatis. Infect Immun 1994;62:1576-83.
14. Peeling RW, Maclean IW, Brunham RC. In vitro neutralization of Chlamydia trachomatis with monoclonal antibodies to an epitope on the major outer membrane protein. Infect Immun 1984;46:484-8.
15. Zhang Y-X, Stewart S, Joseph T, Taylor HR, Caldwell HD. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J Immunol 1987;138:575-81.
16. Brunham RC, Kuo CC, Cles L, Holmes KK. Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun 1983;39:1491-4.
17. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996;383:787-93.
18. Mosmann TR, Subash S. The expanding universe of T cell subsets: Th1, Th2 and more. Immunol Today 1996;17:138-46.
19. Moulder JW. Comparative biology of intracellular parasitism. Microbiol Rev 1985;49:298-337.
20. Moulder JW. Interaction of chlamydiae and host cells in vitro. Microbiol Rev 1991;55:143-90.
21. Friis RR. Interaction of L cells and Chlamydia psittaci: entry of the parasite and host responses to its development. J Bacteriol 1972;110:706-21.
22. Marrack P, Kappler J. Subversion of the immune system by pathogens. Cell 1994;76:323-32.
23. Dhir SP, Boatman ES. Location of polysaccharide on Chlamydia psittaci by silver-methenamide staining and electron microscopy. J Bacteriol 1972;111:267-71.
24. Hatch TP, Vance DW Jr, Al-Hossainy E. Identification of a major envelope protein in Chlamydia spp. J Bacteriol 1981;146:426-9.
25. Brade L, Nurminen M, Makela PH, Brande H. Antigenic properties of Chlamydia trachomatis lipopolysaccharide. Infect Immun 1985;48:569-72.
26. Caldwell HD, Hitchcock PJ. Monoclonal antibody against a genus-specific antigen of Chlamydia species: location of the epitope on the chlamydial lipopolysaccharide. Infect Immun 1984;44:306-14.
27. Caldwell HD, Kromhaut J, Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 1981;31:1161-76.
28. Birkelund S, Stephens RS. Construction of physical and genetic maps of Chlamydia trachomatis serovar L2 by pulsed-fleld gel electrophoresis. J Bacteriol 1992;174:2742-7.
29. Fukushi H, Hirai K. Proposal of Chlamydia pecorum sp nov for Chlamydia strains derived from ruminants. Int J Syst Bacteriol 1992;42:306-8.
30. Grayston JT, Kuo CC, Campbell LA, Wang S-P. Chlamydia pneumonias sp nov for Chlamydia sp. strain TWAR. Int J Syst Bacteriol 1989;39:88-90.
31. Grayston JT, Aldous MB, Easton A, et al. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis 1993;168:1231-5.
32. Schachter J. Chlamydial infections. N Engl J Med 1978;298:540-8.
33. Ward ME. The chlamydial developmental cycle. In: Barron AL, ed. Microbiology of Chlamydia. Boca Raton: CRC Press, 1988:71-95.
34. Grayston JT, Wang S-P. New knowledge of Chlamydia and the diseases they cause. J Infect Dis 1975;132:87-104.
35. Kuo CC. Host response. In: Barron AL, ed. Microbiology of Chlamydia. Boca Raton: CRC Press, 1988:193-208.
36. Kuo CC, Chen WJ. A mouse model of Chlamydia trachomatis pneumonitis. J Infect Dis 1981;141:198-202.
37. Thomas SM, Garrity LF, Brandt CR, et al. IFNγ mediated antimicrobial response. Indoleamine 2,3-dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp or Toxoplasma growth. J Immunol 1993;150:5529-34.
38. Williams DM, Schachter J, Drutz DJ, Sumaya CV. Pneumonia due to Chlamydia trachomatis in the immunocompromised (nude) mouse. J Infect Dis 1981;143:238-41.
39. Brunham RC, Kuo CC, Chen W-J. Systemic Chlamydia trachomatis infection in mice: a comparison of lymphogranuloma venereum and trachoma biovars. Infect Immun 1985;48:78-82.
40. Starnbach MN, Bevan MJ, Lampe MF. Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis. J Immunol 1994;153:5183-9.
41. Whittum-Hudson JA, O'Brien TP, Predergast RA. Murine model of ocular infection by a human biovar of Chlamydia trachomatis. Invest Ophthalmol Vis Sci 1995;36:1976-87.
42. Gogolak FM. The histopathology of murine pneumonitis infection and the growth of the virus in the mouse lung. J Infect Dis 1953;92:254-60.
43. Nigg C, Eaton MD. Isolation from normal mice of a pneumotropic virus which forms elementary bodies. J Exp Med 1944;79:497-509.
44. Barron AL, White HJ, Rank RG, Soloff BL, Moses EB. A new animal model for the study of Chlamydia trachomatis genital infections: infection of mice with the agent of mouse pneumonitis. J Infect Dis 1981;143:63-6.
45. Swenson CE, Donnegan E, Schachter J. Chlamydia trachomatis-induced salpingitis in mice. J Infect Dis 1983;148:1101-7.
46. Swenson CE, Schachter J. Infertility as a consequence of chlamydial infection of the upper genital tract in female mice. Sex Transm Dis 1984;11:64-7.
47. Williams DM, Schachter J, Grubbs B, Sumaya CV. The role of antibody in host defence against the agent of mouse pneumonitis. J Infect Dis 1982;145:200-5.
48. Williams DM, Schachter J, Weiner MH, Grubbs B. Antibody in host defence against mouse pneumonitis agent (murine Chlamydia trachomatis). Infect Immun 1984;45:674-8.
49. Williams DM, Schachter J, Coalson JJ, Grubbs B. Cellular immunity to the mouse pneumonitis agent. J Infect Dis 1984;149:630-9.
50. Williams DM, Schachter J. Role of cell-mediated immunity in Chlamydial infection: implications for ocular immunity. Rev Infect Dis 1985;7:754-9.
51. Rank RG, Soerberg LSF, Barron AL. Chronic chlamydial genital infection in congenitally athymic nude mice. Infect Immun 1985;48:847-9.
52. Williams DM, Grubbs B, Schachter J. Primary murine Chlamydia trachomatis pneumonia in B-cell-deficient mice. Infect Immun 1987;55:2387-90.
53. Ramsey KH, Soderberg LSF, Rank RG. Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection. Infect Immun 1988;56:1320-5.
54. Ramsey KH, Rank RG. Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines. Infect Immun 1991;59:925-31.
55. Igietseme JU, Ramsey KH, Magee DM, Williams DM, Kincy TJ, Rank RG. Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone. Reg Immunol 1993;5:317-24.
56. Magee DM, Igietseme JU, Smith JG, et al. Chlamydia trachomatis pneumonia in the severe combined immunodeficiency (SCID) mouse. Reg Immunology 1993;5:305-11.
57. Pavia CS, Schachter J. Failure to detect cell-mediated cytotoxicity against Chlamydia trachomatis-infected cells. Infect Immun 1983;39:1271-4.
58. Qvigstad E, Hirschberg H. Lack of cell-mediated cytotoxicity towards Chlamydia trachomatis infected target cells in humans. Acta Pathol Microbiol Immunol Scand [C] 1984;92:153-9.
59. Monaco JJ. A molecular model of MHC class-I-restricted antigen processing. Immunol Today 1992;13:173-9.
60. Igietseme JU, Magee DM, Williams DM, Rank RG. Role of CD8+ T cells in antichlamydial immunity defined by chlamydia-specific T-lymphocyte clones. Infect Immun 1984;62:5195-7.
61. Beatty PR, Stephens S. CD8+ T lymphocyte-mediated lysis of Chlamydia-infected L cells using an endogenous antigen pathway. J Immunol 1994;153:4588-95.
62. Landers DV, Erlich K, Sung M, Schachter J. Role of L3T4-bearing T-cell populations in experimental chlamydial salpingitis. Infect Immun 1991;59:3774-7.
63. Magee DM, Williams DM, Smith JG, et al. Role of CD8 T cells in primary Chlamydia infection. Infect Immun 1995;63:516-21.
64. Su H, Caldwell HD. CD4 T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect Immun 1995;63:3302-8.
65. Shemer-Avni Y, Holtmann H, Wallach D, Sarov I. Cytokine-cell interactions resulting in Chlamydia trachomatis inhibition-mechanism involved. In: Bowie WR, Caldwell HD, Jones RP, et al, eds. Chlamydia Infections. Cambridge: Cambridge University Press, 1990:173-6.
66. Dayer J-M, de Rochemonteix B, Burrus B, Demczuk S, Dinarello CA. Human recombinant interleukin-1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest 1986;7:645-8.
67. Raines EW, Dower SK, Ross R. Interleukin 1 mitogen activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 1989;243:393-6.
68. Magee DM, Smith JG, Bleicker CA, et al. Chlamydia trachomatis pneumonia induces in vivo production of interleukin-1 and -6. Infect Immun 1992;60:1217-20.
69. Manor HE, Sarov I. Inhibition of chlamydia trachomatis replication in HEP-2 cells by human monocyte-derived macrophages. Infect Immun 1988;56:3280-4.
70. Shemer-Avni Y, Wallach D, Sarov J. Inhibition of chlamydia trachomatis growth by recombinant tumor necrosis factor. Infect Immun 1988;56:2503-6.
71. Williams DM, Magee DM, Bonewald LF, et al. A role in vivo for tumor necrosis factor alpha in host defence against Chlamydia trachomatis. Infect Immun 1990;57:1572-6.
72. Magee DM, Williams DM, Wing EJ, Bleicker CA, Schachter J. Production of colony-stimulating factors during pneumonia caused by Chlamydia trachomatis. Infect Immun 1991;59:2370-5.
73. Williams DM, Schachter J, Grubbs B. Role of natural killer cells in infection with the mouse pneumonitis agent (murine Chlamydia trachomatis). Infect Immun 1987;55:223-6.
74. Byrne GI, Krueger DA. Lymphokine-mediated inhibition of Chlamydia replication in mouse fibroblasts is neutralized by anti-gamma Interferon immunoglobulin. Infect Immun 1983;42:1152-8.
75. de la Maza LM, Plunkett MJ, Carlson EJ, Peterson EM, Czarniecki CW. Ultrastructural analysis of the anti-chlamydial activity of recombinant murine interferon-y. Exp Mol Pathol 1987;47:13-25.
76. Rothermel CD, Byrne GI, Havell EA. Effect of Interferon on the growth of Chlamydia trachomatis in mouse fibroblasts (L cells). Infect Immun 1983;39:362-70.
77. Shemer-Avni Y, Sarov J. Inhibition of growth of Chlamydia trachomatis by human y Interferon. Infect Immun 1985;48:592-6.
78. Byrne GI, Grubbs B, Dickey TJ, Schachter J, Williams DM. A role for Interferon in recovery from pneumonia due to Chlamydia trachomatis in the mouse. J Infect Dis 1987;156:933-96.
79. Williams DM, Byrne GI, Grubbs B, Marshal TJ, Schachter J. Role in vivo for gamma Interferon in control of pneumonia caused by Chlamydia trachomatis in mice. Infect Immun 1988;56:3004-6.
80. Williams DM, Grubbs BG, Schachter J, Magee DM. Gamma Interferon levels during Chlamydia trachomatis pneumonia in mice. Infect Immun 1993;61:3556-8.
81. Zhong G, Peterson EM, Czaniechi CW, Schreiber RD, de la Maza LM. Role of endogenous gamma Interferon in host defence against Chlamydia trachomatis infection. Infect Immun 1989;57:152-7.
82. Zhong G, Peterson EM, Czaniechi CW, Schreiber RD, de la Maza LM. Recombinant murine gamma Interferon inhibits Chlamydia trachomatis serovar L1 in vivo. Infect Immun 1988;56:283-6.
83. Byrne GI, Lehmann JK, Landry GJ. Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun 1986;53:347-51.
84. Nussler AK, Billiar TR. Inflammation, immunoregulation and inducible nitric oxide synthase. J Leuk Biol 1993;54:171-8.
85. Woods ML, Mayer J, Evans TG, Hibbs JB. Antiparasitic effects of nitric oxide in an in vitro model of chlamydia trachomatis infection and an in vivo model of Leishmania major infection. Immunol Ser 1994;60:179-95.
86. Igietseme JU, Uriri IM, Hawkins R, Rank RG. Integrin-mediated epithelial-T cell interaction enhances nitric oxide production and increased intracellular inhibition of chlamydia. J Leuk Biol 1996;59:656-62.
87. Igietseme JU. The molecular mechanism of T-cell control of chlamydial in mice: role of nitric oxide. Immunology 1996;87:1-8.
88. Beagley KW, Eldridge JH, Kiyono H, et al. Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells. J Immunol 1988;141:2035-42.
89. Beagley KW, Eldridge JH, Lee F, et al. Interleukins and IgA synthesis: human and murine IL-6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med 1989;169:2133-48.
90. Coffman RL, Varkila K, Scott P, Chatelain R. Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo. Immunol Rev 1991;123:189-207.
91. VanCott JL, Staats HF, Pascual DW, et al. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J Immunol 1996;156:1504-14.
92. Kelso A. Th1 and Th2 subsets: Paradigms lost? Immunol Today 1995;16:374-9.
93. Mosmann TR, Coffman RL. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
94. Heinzel FP, Sadick MD, Mutha SS, Locksley RM. Production of interferon y, interleukin 2, interleukin 4, and interleukin 10 by CD4 lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci USA 1991;88:7011-5.
95. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994;12:227-57.
96. Scott P, Kaufmann SHE. The role of T-cell subsets and cytokines in the regulation of infection. Immunol Today 1991;12:346-8.
97. Yang X, Gieni RS, Mosmann TR, HayGlass KT. Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo. J Exp Med 1993;178:349-53.
98. Cain TK, Rank RG. Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun 1995;63:1784-9.
99. Yang X, HayGlass KT, Brunham RC. Genetically determined differences in IL-10 and IFNγ responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol 1996;156:4338-44.
100. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell IV: Th2 clones secret a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-95.
101. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra AO. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
102. Macatonia SE, Doherty TM, Knight SC, O'Garra A. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol 1993;150:3755-65.
103. Igietseme JU, Wyrick PB, Goyeau D, Rank RG. An in vitro model for immune control of chlamydial growth in polarized epithelial cells. Infect Immun 1984;62:3528-35.
104. Capecchi MR. Altering the genome by homologous recombination. Science 1989;244:1288-92.
105. Koller BH, Smithies O. Inactivating the 62-microglobulin locus in mouse embryonic stem cells by homologous recombination. Proc Natl Acad Sci USA 1989;86:8932-5.
106. Grusby MJ, Johnson RS, Papaioannou VE, Glimcher LH. Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science 1991;253:1417-20.
107. Morrison RP, Feilzer K, Tumas DB. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect Immun 1995;63:4661-8.
108. Haas W, Pereira P, Tonegawa S. Gamma/delta cells. Annu Rev Immunol 1993;11:637-85.
109. Kaufmann SHE, Ladel CH. Role of T cell subsets in immunity against intracellular bacteria: Experimental infections of knock-out mice with Listeria monocytogenes and Mycobacterium bovis BCG. Immunobiology 1994;191:509-19.
110. Kaufmann SHE. Immunity to intracellular bacteria. In: William EP, ed. Fundamental Immunology, 3rd edn. New York: Raven Press, 1993:1251-86.
111. Mombaerts PJ, Arnoli J, Russ F, Tonegawa S, Kaufmann SHE. Different roles of alpha-beta and gamma-delta T cells in immunity against an intracellular bacterial pathogen. Nature (Lond) 1993;365:53-6.
112. Mombaerts P, Clarke AR, Rudnick MA, et al. Mutations in T-cell antigen receptor genes α and βblock thymocyte development at different stages. Nature 1992;360:225-31.
113. Itohara S, Mombaerts P, Lafaille J, et al. T cell receptor δ gene mutant mice: independent generation of αβ T cells and programmed rearrangements of γδ TCR genes. Cell 1993;72:337-48.
114. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992;68:869-77.
115. Williams DM, Grubbs BG, Kelly K, Pack E, Rank R. Role of gamma-delta T cells in Chlamydia trachomatis infection. Infect Immun 1996;64:3916-9.
116. Fuentes V, Orfila J. Genetic control of natural resistance to Chlamydia psittaci loth strain in mice. In: Bowie WR, Caldwell HD, Jones RP, et al, eds. Chlamydial Infections, Proceeding of the Seventh International Symposium on Human Chlamydial Infection. Cambridge: Cambridge University Press, 1990:232-5.
117. Graham DM, Triglia T. Genetic control of responsiveness of mice to Chlamydia trachomatis pneumonitis. In: Driel D, Ridgway G, Schachter J, Taylor-Robinson D, Ward M, eds. Chlamydial Infections, Proceedings of the Sixth International Symposium on Human Chlamydial Infection. Cambridge: Cambridge University Press, 1986:396-9.
118. Tuffrey M, Alexander F, Woods C, Taylor-Robinson D. Genetic susceptibility to Chlamydial salpingltis and subsequent infertility in mice. J Reprod Fert 1992;95:31-8.
119. Hanna L, Schmidt L, Sharp M. Human cell-mediated immune responses to Chlamydial antigen. Infect Immun 1979;23:412-7.
120. Brunham RC, Martin DH, Kuo C-C, et al. Cellular immune response during uncomplicated genital infection with Chlamydia trachomatis in humans. Infect Immun 1981;34:98-104.
121. Bailey RL, Kajbaf M, Whittle HC, Ward ME, Mabey DCW. The influence of antichlamydial antibody on the acquisition and persistence of human ocular chlamydial infection: IgG antibodies are not protective. Epidemiol Infect 1993;111:315-24.
122. Bailey RL, Holland MJ, Whittle HC, Mabey DCW. Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative responses to chlamydial antigens compared with those of persistently diseased controls. Infect Immun 1993;63:389-92.
123. Bailey RL, Mabey DCW. Immunity to Chlamydia trachomatis: lessons from a Gambian village. J Med Microbiol 1996;45:1-2.
124. Holland MJ, Bailey RL, Hayes LJ, Whittle HC, Mabey DCW. Conjunctival scarring in trachoma is associated with depressed cell-mediated immune responses to Chlamydial antigens. J Infect Dis 1993;168:1528-31.
125. Holland MJ, Bailey RL, Conway DJ, et al. T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring. Clin Exp Immunol 1996;105:429-35.
126. Chow JM, Yonekura ML, Richwald GA, Greenland S, Sweet RL, Schachter J. The association between Chlamydia trachomatis and ectopic pregnancy. JAMA 1990;263:3164-7.
127. Punnonen R, Terho P, Nikkanen V, Meurman O. Chlamydial serology in infertile women by immunofluorescence. Fertil Steril 1979;31:656-9.
128. Bretscher PA. A strategy to improve the efficacy of vaccination against tuberculosis and leprosy. Immunol Today 1992;13:342-5.
129. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 1992;257:539-42.
130. Brunham RC, Kimani J, Bwayo J, et al. The epidemiology of Chlamydia trachomatis within a sexually transmitted disease core group. J Infect Dis 1996;173:950-6.
131. Kimani J, Maclean IW, Bwayyo JJ, et al. Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya. J Infect Dis 1996;173:1437-44.
132. Turk JL, Bryceson ADM. Immunological phenomena in leprosy and related diseases. Adv Immunol 1971;13:209-70.
133. Wyrick PB, Brownridge EA. Growth of Chlamydia psittaci in macrophage. Infect Immun 1978;19:1054-60.
134. Scott P. IL-12: Initiation cytokine for cell-mediated immunity. Science 1993;260:496-7.
135. Seder RA, Paul WE. Acquisition of lymphokine-producing phenotype by CD4 T cells. Annu Rev Immunol 1994;12:635-73.
136. McDonnell WM, Askari FK. Molecular medicine DNA vaccines. N Engl J Med 1996;334:42-5.
137. Pardoll DM, Beckerleg AM. Exposing the immunology of naked DNA vaccines. Immunity 1995;3:165-9.
138. Zhang D-J, Yang X, Brunham RC. DNA vaccination with the MOMP gene protects against Chlamydia trachomatis infection. J Infect Dis 1997;176:1035-40.